News
Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
Decongestants with the same brand name may contain two different active ingredients. And, by nearly every account, one of them doesn’t work.
The panelists flagged safety concerns with Blenrep and GSK’s failure to optimize its dosing regimen for the antibody-drug ...
FDA regulators said Thursday that Juul’s studies show its e-cigarettes are less harmful for adult smokers, who can benefit ...
FDA authorizes Juul’s tobacco- and menthol-flavored e-cigarettes to stay on U.S. shelves, reversing a previous ban due to new ...
1h
Flow Space on MSNFDA Experts Call for Rethink on Menopause Hormone Therapy WarningsOn Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
The US Food and Drug Administration aims to revoke 52 standards of identity (SOI) across a swath of food categories, claiming ...
Panelists discuss how payers can evaluate BTK inhibitors by considering specific MS phenotypes and FDA indications rather ...
Coffee pods sold nationwide are under recall for a possible health issue, according to notices posted by the company and the ...
Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, ...
Rich Ice Cream Co. recalled numerous lots of its products on June 27 over potential contamination with Listeria monocytogenes ...
An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results